Kansas City Cancer Centers-Central

Kansas City, Missouri 64111

0 studies enrolling now · 4 studies all time

What they study most

Hormone-refractory Prostate Cancer, Leukemia, Lung Cancer, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Non-Hodgkin's Lymphoma

Studies at this site

• Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer — Completed
• Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer — Completed
• Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel — Completed
• Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma — Stopped early